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CCL5 (RANTES) is a proinflammatory chemokine
known to activate leukocytes through its receptor,
CCR5. Although the monomeric form of CCL5 is
sufficient to cause cell migration in vitro, CCL5’s
propensity for aggregation is essential for migration
in vivo, T cell activation and apoptosis, and HIV entry
into cells. However, there is currently no structural
information on CCL5 oligomers larger than the
canonical CC chemokine dimer. In this study the
solution structure of a CCL5 oligomer was investi-
gated using an integrated approach, including NMR
residual dipolar couplings to determine allowed
relative orientations of the component monomers,
SAXS to restrict overall shape, and hydroxyl radical
footprinting and NMR cross-saturation experiments
to identify interface residues. The resulting model
of the CCL5 oligomer provides a basis for explaining
the disaggregating effect of E66 and E26 mutations
and suggests mechanisms by which glycosamino-
glycan binding may promote oligomer formation
and facilitate cell migration in vivo.
INTRODUCTION
Chemokines are an important class of immunoactive-signaling
molecules that activate leukocytes through chemokine family
G protein-coupled receptors (GPCRs). They are widely ex-
pressed by many cells in different contexts, including immune
surveillance and inflammation. In all cases the establishment of
chemokine concentration gradients on endothelial layers and
in the surrounding tissue provides directional cues to guide cell
movement. One factor that may be vital to the establishment
and maintenance of a gradient is the chemokines’ ability to
oligomerize (Appay et al., 1999; Czaplewski et al., 1999).
Although monomeric mutants of chemokines are capable of
causing cell migration in vitro (Laurence et al., 2000; Paavola
et al., 1998; Proudfoot et al., 2003; Rajarathnam et al., 1994),
several studies using nonoligomerizing variants have shown
that induction of migration in vivo is dependent on oligomeriza-
tion (Appay et al., 1999; Campanella et al., 2006; Johnson
et al., 2004; Proudfoot et al., 2003). Moreover, chemokines that
are unable to oligomerize have shown therapeutic benefit in1138 Structure 19, 1138–1148, August 10, 2011 ª2011 Elsevier Ltd Aa number of animal models of inflammatory disease (Brauners-
reuther et al., 2010; Johnson et al., 2004), underscoring the
importance of understanding oligomeric interactions.
Although some chemokines can form large oligomers in isola-
tion, oligomerization of chemokines is promoted by interaction
with glycosaminoglycans (GAGs), which are sulfated polysac-
charides that reside on cell surfaces and in the extracellular
matrix. The importance of chemokine:GAG interactions was
demonstrated experimentally when chemokine mutants compe-
tent to bind receptor, but incapable of binding GAGs, were
shown to be unable to activate cell migration in vivo, presumably
because GAG interactions are also important for establishing
a haptotactic chemokine gradient (Johnson et al., 2004;
Murooka et al., 2006; Proudfoot et al., 2003). Chemokine:GAG
interactions have also been shown to be important for processes
separate from migration, such as T cell activation and induction
of apoptosis (Johnson et al., 2004; Murooka et al., 2006;
Proudfoot et al., 2003).
Structural knowledge of chemokine oligomers alone and in
complex with GAGs could clearly provide insight into the
molecular mechanisms by which chemokines facilitate the
recruitment and activation of leukocytes in vivo. But there is
currently relatively little information on the mechanisms of
chemokine oligomerization. Where models for quaternary
assemblies of chemokines larger than dimers do exist, they
have been deduced from crystal structures (Hoover et al.,
2000; Jabeen et al., 2008; Jin et al., 2010; Lau et al., 2004;
Murphy et al., 2010; Ren et al., 2010; Swaminathan et al.,
2003). Most recently, Ren et al. (2010) solved the crystal
structures of MIP-1a/b oligomers, and whereas SAXS data
support the presence of similar structures in solution, this is
one of the few cases where such experimental evidence exists.
For many chemokines there are no data on structures of oligo-
mers in either crystals or solution.
CCL5 is a particularly aggregation-prone member of the
chemokine family, and one for which no structural data on higher
oligomers exist. This proinflammatory chemokine is secreted
by both endothelial cells and activated leukocytes to attract
leukocytes to sites of inflammation. In addition to migration,
oligomerization of CCL5 has been shown to be important
for its ability to cause generalized T cell activation through
protein tyrosine kinases and for induction of apoptosis (Appay
et al., 1999; Murooka et al., 2006). Furthermore, these processes
were shown to involve G protein(Gai)-independent activation
of its receptor CCR5 (Appay et al., 1999; Murooka et al.,
2006), suggesting that oligomeric CCL5 activates different
signaling pathways than those induced by monomeric CCL5.ll rights reserved
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Structure of the CCL5 OligomerThus, monomeric and oligomeric CCL5s appear to act as ‘‘func-
tionally selective’’ or ‘‘biased’’ ligands of CCR5, terms usually
reserved for different ligands of the same receptor (Keov et al.,
2011).
In addition to cell migration, CCR5 plays a crucial role in
mediating HIV entry into T cells and monocytes. In this context,
differences in oligomerization state also have functional
consequences. Although high concentrations of aggregation-
competent wild-type (WT) CCL5 promote HIV entry, low
concentrations of CCL5 and mutants incapable of forming large
aggregates suppress HIV infection (Czaplewski et al., 1999).
Inhibition of HIV entry with low concentrations of CCL5 or
mutants is thought to involve binding of monomeric CCL5 to
CCR5, by physically blocking access to the receptor, and
causing receptor internalization; and indeed, variants with
a greater propensity to internalize have been shown to be
more potent inhibitors of HIV entry (Escola et al., 2010). By
contrast, high concentrations of oligomerization-competent
CCL5 seem to enhance HIV entry by physical crosslinking of
HIV particles to target cells or by activation of kinase-signaling
pathways through binding to theGAG chains of the proteoglycan
CD44, which in turn impacts the HIV life cycle (Roscic-Mrkic
et al., 2003). Hence, understanding oligomerization tendencies
is potentially important to both control of immune response
and intervention in HIV infection.
Physical characterization of the oligomerization behavior of
CCL5 has previously revealed that it forms large aggregates at
micromolar concentrations in a neutral pH environment but
smaller aggregates at reduced pH. The fact that large
aggregates dissociate into dimers at pH 3–4, as well as the
existence of mutants that limit oligomerization (Czaplewski
et al., 1999), has allowed dimer characterization by both NMR
and X-ray crystallography (Chung et al., 1995; Skelton et al.,
1995). Structural studies have also been carried out on other
CCL5 mutants and complexes with GAG disaccharides under
conditions that favor dimers (Jin et al., 2010; Shaw et al., 2004;
Wilken et al., 1999). But, none of the structures provides insight
into the quaternary conformation of CCL5 higher-order
oligomers.
UtilizingWT CCL5’s relatively high solubility at an intermediate
pH (4.5), we now present CCL5’s higher oligomeric structures
using solution NMR, SAXS, and hydroxyl radical footprinting
mass spectrometry (MS). NMR and SAXS data revealed that
the size distribution of the CCL5 oligomer at pH 4.5 is primarily
a tetramer. Relative orientations of the dimeric units within the
tetramer were determined by NMR residual dipolar coupling
(RDC) data, which significantly restrict the number of possible
configurations that the tetramer can adopt. Shape information
from SAXS was then used to find the best translational
placement of the dimers within the tetramer. The interaction
interfaces between the dimers were confirmed using both
NMR cross-saturation experiments and hydroxyl radical
footprinting MS. Together, these data provide information not
only on the assembly of the tetramer but also on the formation
of linear higher-order aggregates. The resulting model shows
that both GAG-binding sites and residues known to interact
with CCR5 are exposed in a linear array, possibly facilitating
movement of leukocytes along cell surfaces and aiding
pathogen entry in vivo.Structure 19, 1138–RESULTS
Symmetry of the WT CCL5 Tetramer
The oligomerization state of WT CCL5 at a concentration of
1 mM and pH 4.5 was investigated using pulse gradient
diffusion NMR, and correlation times from NMR spin-relaxation,
dynamic light-scattering, and SAXS data. NMR data clearly
showed diffusional properties consistent with a tetramer. Light-
scattering and SAXS data indicated the presence of some higher
oligomers in addition to tetramers (see Figure S1 available
online). A two-dimensional (2D) 1H-15N HSQC (heteronuclear
single quantum coherence) spectrum of an 15N-labeled CCL5
sample under these conditions (Figure S2) revealed only one
set of cross-peaks, one for each protonated amide in the
sequence, suggesting that the oligomers formed are symmetric
structures, at least when averaged over the NMR timescale.
Determination of structures for symmetric complexes can be
approached with NOE-based NMR experiments, but only with
mixed isotopic-labeling strategies and experiments that have
low sensitivity (Clore and Gronenborn, 1998). Instead, we opted
to employ RDC measurements (Al-Hashimi et al., 2000;
Prestegard et al., 2004). The resulting data are sensitive to
orientations of N-H bond vectors relative to the magnetic field
andprovide both a test for preservation of themonomer structure
as observed by X-ray crystallography (Tjandra and Bax, 1997;
Tolman et al., 1995) and information on the orientation of mono-
mers in higher-order structures (Al-Hashimi et al., 2000). RDCs
for WT CCL5 aligned in both neutral and positively charged
polyacrylamide gel and the dimer-forming E66S mutant aligned
in neutral polyacrylamide gel were measured. Not surprisingly,
the RDCs for the E66S mutant fit very well to those back calcu-
lated from a monomer in the dimer crystal structure (correlation
coefficient 0.96, Q factor 0.24). More surprisingly, both sets of
RDCdata collected on theWTCCL5 tetramer fit the crystal struc-
ture nearly as well (Figure S3, correlation coefficient 0.96 and
0.95, Q factor 0.26 and 0.29 for neutral and positively charged
gel RDC, respectively). This indicates preservation of the dimer
structure within the tetramer structure.
RDCs can also be used to identify an axis of rotational
symmetry. For the E66S mutant one axis of the principal align-
ment frame determined from RDC data very closely aligned to
the C2V symmetry axis observed in the crystal structure. The
alignment tensor orientation and C2V symmetry axis for the WT
CCL5 tetramer were determined independently by comparing
alignment frame directions from data collected in neutral and
positively charged gels. Figure 1A shows the directions of prin-
cipal alignment frame axes for both media as viewed from the
crystal structure coordinate frame. The projection plot shows
that only one of the axis directions is preserved (the x axis).
Because a C2V symmetry axis must be parallel to an alignment
frame principal axis regardless of alignment media (Al-Hashimi
et al., 2000), this unambiguously identifies the symmetry axis
of the tetramer. Figure 1B shows the orientation of the alignment
frame for WT CCL5 aligned in positively charged gel. The dimer
symmetry axis as seen in the crystal structure differs by only 5.5
from the x axis of the alignment frame. The principal Sxx order
parameter for WT CCL5 aligned in positively charged gel
is 1.23 3 104, whereas the order parameters for the y and
z axes are nearly equal in magnitude (Syy = 8.82 3 104;1148, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1139
Figure 1. Symmetry Axis Determination
from RDC Data
(A) Sauson-Flamsteed projection plot of alignment
frame orientations for WT CCL5 aligned in both
positively charged and neutral polyacrylamide gel.
The x axes of the two frames share a common
orientation.
(B) Orientation of the alignment tensor relative to
the CCL5 dimer. The x axis of the principal axes of
the alignment tensor is shown in red, the y axis is
shown in blue, and the z axis is in orange. The
golden arrow indicates the orientation of the
symmetry axis from the dimer crystal structure
(see also Figures S2 and S3).
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Structure of the CCL5 OligomerSzz = 1.01 3 103), leading to an asymmetry parameter of 0.75.
Comparison of order parameters for WT CCL5 and the E66S
dimer aligned in a neutral gel show similar asymmetry parame-
ters but slightly lower order for the dimer (Sxx = 0.11 3 104,
Syy = 6.30 3 104, and Szz = 6.41 3 104 versus Sxx =
0.70 3 104, Syy = 7.40 3 104, and Szz = 8.09 3 104).
The identification of the symmetry axis and preservation of the
dimer structure places substantial restrictions on the structure of
the tetramer. Except for a special case in which dimers stack
along the symmetry axis, all allowed tetramers must have
interdimer-binding interfaces that are restricted to a band of
residues that make contact through translation of one member
of a properly oriented dimer pair in the YZ plane. This restriction
arises because translational motion parallel to the symmetry axis
would break the symmetry. The special case of a stacked
tetramer is unlikely because order parameters suggest that the
overall shape of the tetramer is similar to that of the dimer, and
the stacked version would be much more globular. Elimination
of the globular structure was also confirmed using SAXS data,
as described below.
Shape Restrictions from SAXS Data
SAXS data are particularly sensitive to the spatial distribution of
electron density of the dominant species in solution. Data were1140 Structure 19, 1138–1148, August 10, 2011 ª2011 Elsevier Ltd Acollected on a sample containing 1.25 mM WT CCL5 at
pH 4.5. The resulting scattering curve is shown in Figure 2A along
with fits to models as described below. Among the parameters
most relevant to distinguishing models are the radius of gyration
from a Guinier plot and the maximum pairwise distance between
heavy atoms from a pair-density distribution function, which
have values of 31 and 121 A˚, respectively (Figure S4). The
radius of gyration is consistent with an in-plane tetramer model,
and particularly, the maximum pairwise distance is more consis-
tent with the 122 A˚ extension of an in-plane hexamer than the
70 A˚ extension of a stacked dimer model.
Modeling Using a Symmetry-Restricted Grid Search,
SAXS, and Residue-Pairing Score
Given the restrictions on the symmetry and shape of the
tetramer, a simple grid search was used to generate all possible
models satisfying the symmetry constraints, using a procedure
similar to that described by Wang et al. (2008). However,
additional degrees of freedom were added to allow small
symmetry-preserving rotations around the y and z axes
(15 and 5, respectively) to take into account errors in deter-
mining the symmetry axis. The models were subsequently
screened for agreement with the SAXS profile (Figure 2B) and
a favorable binding surface using a residue-pairing scoreFigure 2. Translation Optimization from
SAXS Data
(A) Fitting to SAXS data for the model refined from
grid point 19 3 13, c2 = 1.13. Forty percent of the
protein is assumed in be in the tetramer form.
(B) Contour map of the SAXS-fitting c2 values of
the models generated on the grid. Colors ranging
fromblue to yellow represent high to low c2 values,
respectively (see also Figure S4).
ll rights reserved
Figure 3. Tetramer Model from SAXS and
Residue Pair Scores
(A) Contour maps of the combined residue pair
and SAXS scores for each model on the grid.
(B) Model from grid point 19 3 13, which is
representative of the models from the group with
the best (orange region) combined score (see also
Figure S5).
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Structure of the CCL5 Oligomer(Figure S5) (Moont et al., 1999). During the SAXS profile fitting,
the presence of a tetramer-hexamer equilibrium was treated
through the use of the program OLIGOMER (Konarev et al.,
2006). The hexamer model was produced by adding an addi-
tional dimer unit to the tetramer, duplicating the initial dimer-
dimer interface, and then adjusting the tetramer-hexamer ratio
to find the best fit to the SAXS data. Monomers and dimers
were not included in the simulations; the dimer dissociation
constant for the WT at pH 3.8 has been determined to be
18 mM (Duma et al., 2007; Skelton et al., 1995). This suggests
that only a small percentage of monomers are present at
concentrations used in the SAXS experiments. Figure 2B shows
the contour map of c2 values of the SAXS fitting for models
produced at each grid point. To improve selectivity, a score
combining both SAXS c2 values and a residue pair score was
created to select models (see Figure 3A and Experimental
Procedures). One group of models centered around the grid
point 19 3 13 gave the best combined score. The best fit of
model 19 3 13 to the experimental SAXS curve was obtained
by assuming that 40% of the protein mass existed as tetramer
and the rest as hexamer. Figure 2A shows the comparison of
the theoretically calculated scattering curve of the hexamer/
tetramer mixture of model 19 3 13 with the experimental scat-
tering curve.
Figure 3B shows the model from grid point 19 3 13, which is
representative of the models from the cluster surrounding this
point. The tetramer model is based on an interface formed byFigure 4. Identification of Dimer-Dimer Contacts from Cross-Saturation Data
(A) Plot of residue-specific cross-saturation-induced amide proton signal intensity changes for WT and E66
(B) Surface plot of the CCL5 tetramer model with residues identified as being specifically perturbed in the W
orange and the dimer interface (residues 6–10) colored in red.
Structure 19, 1138–1148, August 10, 2011 ªcontacts between residues 25 and 30 in
the second b strand from one monomer
of dimer A and several residues of the
C-terminal helix from one monomer ofdimer B. A symmetric set of interactions is contributed by the
b strand of dimer B and the C-terminal helix of dimer A. Models
generated from other grid points in the cluster differ from one
another only in small displacements along the y and z axes.
Validating the Binding Interface with NMR
Cross-Saturation Data
To validate the model found in the grid search, the interdimer
interface was probed using solution NMR cross-saturation
(Takahashi et al., 2000). In this method, 15N, 2H-labeled CCL5
was mixed with unlabeled CCL5 in a 1:3 ratio, and mixed dimers
and tetramerswere allowed to form. By applying RF pulses to the
methyl/methylene region of the proton spectrum, sites in the
unlabeled molecules were saturated, and spin diffusion trans-
ferred this saturation across the interface to the nearest
1H15N pairs of labeled molecules. The ratios of HSQC cross-
peak intensities, with and without saturation, provide a measure
of the proximity of various 1H15N pairs to the interface. Both
dimer and tetramer interfaces will be seen, so it is important to
compare experiments for the E66Smutant andWT to distinguish
monomer-monomer from dimer-dimer interfaces. Figure 4A
shows a plot of HSQC saturated/unsaturated signal intensity
ratios for WT and E66S CCL5. Although the two sets of data
are not quantitatively comparable due to differences in rotational
correlation times and resulting differences in spin diffusion
efficiencies, they still serve as a good qualitative guide for iden-
tifying the dimer-dimer interface in the tetramer. For WT CCL5S CCL5.
T (residues 26–29, 33, 34, 66, and 67) colored in
2011 Elsevier Ltd All rights reserved 1141
Figure 5. Identification of Dimer-Dimer Contacts from Hydroxyl Radical Footprinting
(A) Plot of residue-specific hydroxyl radical modification percentage for WT and E66S CCL5. The degree of modification is analyzed at the peptide level, and the
major sites of oxidation are identified at the residue level for each peptide. Residues identified as being protected from modification are indicated.
(B) Surface plot of the CCL5 tetramer with residues identified as being in the tetrameric interface (residues 26–29, 41, 61, 62, 67, and 68) colored orange (see also
Figure S6).
Structure
Structure of the CCL5 Oligomerthe intensities of N-terminal residues 6–8 (red in Figure 4B), 10,
15–17, 23, 26–29, 33–34, and 49–50 are highly reduced.
Additional intensity changes were seen for residues 40–43 and
64–68. Intensity decreases for N-terminal residue signals are
clearly due to interactions at the monomer-monomer interface
in the dimer units because the same residues are perturbed in
spectra of the E66S mutant. Residues 26–29, 33 and 34, and
64–68 were perturbed in the WT data only (orange area in
Figure 4B); they are in the dimer-dimer interface of the tetramer
model and clearly support this model. Perturbation of residues
40–43 and 48–51 are seen in both proteins and can be explained
by the fact that these residues are in the vicinity of the monomer-
monomer interface and may be indirectly saturated by their
proximity to the interfacial residues. The weak saturation of resi-
dues 15–17, as well as 23, seemed perplexing at first; however,
the N terminus of CCL5 is extremely flexible as shown by NMR
dynamics measurements (Figure S1B), and the conformation
of its end is undefined in both crystal and solution structures of
CCL5. In view of these observations, it is conceivable that the
N-terminal residues may transiently interact with residues
15–17 and 23 on the dimeric partner, leading to saturation. On
the whole, the binding interface defined by the cross-saturation
experiment is in agreement with the model found through the
SAXS/RDC grid search procedure.
Validating the Binding Interface through Hydroxyl
Radical Footprinting MS
The binding interface of the CCL5 tetramer was also validated
through hydroxyl radical footprinting MS. UV radiation-induced
hydrogen peroxide radiolysis was used to produce hydroxyl
radicals that rapidly oxidize exposed protein side chains, and
the degree of oxidation was interpreted as an indicator of relative
solvent exposure. By comparing the solvent exposure of the
E66S mutant, which is a mixture of monomer and dimer at the
concentrations studied in this experiment (20 mM [pH 4.5]),
with WT under the same conditions, regions that are protected
in the dimer-dimer interface of the tetramer can be identified
by a decrease in the rate of oxidation. In this experimental setup
the radical was produced and consumed on a sub-microsecond1142 Structure 19, 1138–1148, August 10, 2011 ª2011 Elsevier Ltd Atimescale to ensure that modifications stemming from nonnative
side-chain exposures, i.e., as a result of conformational changes
caused by oxidation of the protein, were kept to a minimum
(Gau et al., 2009). For quantitation the amount of oxidation of
each peptide within CCL5 was determined by measuring the
amount of unmodified peptide compared to an isotopically
labeled control, then MS/MS was used to determine the major
residues oxidized for each peptide, providing amino acid level
resolution. Figure 5A compares the peptides and residues
protected in WT CCL5 to those protected in the E66S mutant.
H23, E26, Y27, F28, Y29, V40, F41, and C50 were found to be
highly protected from oxidation in the WT structures compared
to the E66S dimer, whereas oxidation of M0, P2, Y3, and C11
on the N-terminal peptide and E61, Y62, M67, and S68 on the
C-terminal peptide are only slightly more protected. M0, P2,
Y3, C11, H23, V40, and C50 appear to be protected in the
monomer-monomer interface of the dimer, and their increases
in protection may reflect a depletion of monomer concentration
or some additional stabilization of the dimer on oligomerization.
Figure 5B shows the locations of the remaining protected
residues on the surface of the CCL5 tetramer. It is evident that
the binding surface identified by protection of these residues
from hydroxyl radical footprinting agrees very well with that of
the cross-saturation experiment.
Formation of Higher-Order Oligomers
The nature of the interface in the tetramer structures shown in
Figures 3–5 is one that leads naturally to formation of higher-
order oligomers. Use of residues from only one monomer of
each dimer leaves those residues in the second monomer
open to interactions that propagate the structure to linear
polymers of even order (hexamers, octamers, etc). In addition
to SAXS data indicating a substantial amount of hexamer at
the somewhat higher concentrations used in those experiments,
native spray MS performed on WT CCL5 at pH 4 indicated the
presence of higher oligomers (Figure 6A). Although these data
were acquired at lower injection concentrations (10 mM), the
loss of solvent from electrospray droplets is known to promote
and allow detection of oligomers that normally form at higherll rights reserved
Figure 6. Higher Oligomer Models Suggested by Native Spray Mass Spectrometry Data
(A) Native spraymass spectrum ofWTCCL5 (10 mM) at pH 4.5. Even-numbered oligomers fromdimer to octamer are observed, indicating that the oligomer is built
from a concatenation of dimer substructures.
(B) Surface plot of the CCL5 octamer model with residues perturbed by GAGs (residues 44–48, 55, and 56) shown in red and residues known to contact CCR5 at
pH 6 (residues 16, 17, 21, and 23) shown in blue. The N terminus of CCL5, which is both perturbed by GAGs and known to bind to CCR5 in CCL5 monomer, is
colored yellow.
(C) Electrostatic potential plot of the octamer surface showing large patches of basic regions (blue) throughout the protein.
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Structure of the CCL5 Oligomerconcentrations. In addition to large amounts of monomer and
dimer observed, significant amounts of tetramer, hexamer, and
octamer were also detected, but not trimer, pentamer, or hep-Structure 19, 1138–tamer. These results indicate that the higher-order oligomers
are a result of a concatenation of a dimer substructure, rather
than oligomerization of the monomer structure (which would1148, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1143
Figure 7. Details of the Dimer-Dimer Interface and Comparison to the MIP1a Tetramer
(A) Details of the interdimer hydrophobic interactions in model 19 3 13. The hydrophobic interface is formed by Y27, F28, I62, and L65.
(B) Electrostatic interactions at the dimer-dimer interface. K25, E26, E66, and R44 can form pairs of electrostatic bonds.
(C) Ribbon representations of the proposed CCL5 tetramer (red) and the MIP1a tetramer (blue). A single dimer unit from each tetramer is arranged in identical
orientation.
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Structure of the CCL5 Oligomerlead to odd-numbered oligomers), or oligomerization of a unique
tetramer structure (which would not allow for the formation of
a hexamer). Further support for progressive oligomerization
using the same dimer-dimer interface is seen in hydroxyl radical
footprinting data on a WT CCL5 sample at pH 7, where a higher
level of oligomerization is observed (Figure S6). An overall
increase in protection is seen, possibly due to a decrease in
monomer content and in the percentage of exposed dimer
ends with increased oligomer size. More importantly, the highest
percent increase in protection was observed for the 22–33
peptide that contains several of the residues suggested to
comprise the dimer-dimer interface of the tetramer.
Figure 6B shows amodel of an octamer constructed by joining
four dimers using the same interface contacts identified in the
tetramer. The type of interaction employed in generating this
model would normally propagate indefinitely. The fact that we
observe restriction to fairly small oligomers is likely correlated
with the high positive charge of CCL5 (pI of 9). The increasing
net charge with increase in oligomer size would serve to
decrease the association constant for addition of each new
dimer. Figure 6C shows the electrostatic potential surface plot
of the CCL5 octamer. It is evident from the extensive positive
patches on the complex that large electrostatic repulsions can
be generated, particularly at pH 4.5, where additional proton-
ation of some carboxylate groups can occur. However, the
situation may be quite different in the presence of negatively
charged GAGs and at more physiological pH, as suggested
from analytical ultracentrifugation studies (Czaplewski et al.,
1999) and native spray MS of WT CCL5 at pH 7, which revealed
a very broad, unresolved peak consistent with the presence of
very large, highly charged, and heterogeneous oligomers (data
not shown).DISCUSSION
The studies presented here suggest a compelling oligomeriza-
tion model for the proinflammatory chemokine CCL5. The model
was generated by integrating complementary data frommultiple
techniques, including existing crystal structures of dimers,1144 Structure 19, 1138–1148, August 10, 2011 ª2011 Elsevier Ltd Asolution NMR data, SAXS data, and hydroxyl radical footprinting
MS. The results show that CCL5 is capable of oligomerizing
without significantly changing its dimeric structure or the orienta-
tion of a C2V symmetry axis. SAXS data are inconsistent with the
formation of more globular tetramer structures, such as those
observed for MCP-1 and IP-10 (Lau et al., 2004; Swaminathan
et al., 2003). Instead, the resulting model is elongated, providing
a mechanism for propagating interactions among dimer units
into long linear polymeric chains containing an even number of
monomer units.
Molecular Basis of the Dimer-Dimer Interaction
The interaction interface identified through a combination of
hydroxyl radical footprinting and NMR cross-saturation data is
primarily composed of contacts between residues 25 and 30 in
the second b strand and residues at the C-terminal helix of
monomer A of one dimer and similar residues in the neighboring
dimer. The contact surface is approximately 860 A˚2 and is
stabilized by a mixture of hydrophobic and electrostatic interac-
tions at the interface. In particular, Y27 and F28 are situated in
the middle of the interface with Y27s on separate dimer units
forming aromatic ring-stacking interactions. F28 provides
a further hydrophobic-interaction surface by making cross-unit
contacts with and L65 and I62 on the C terminus (Figure 7A).
The interface also appears to be stabilized by an intermolecular
salt bridge between K25 on one dimer unit and E26 from the
neighboring unit, with both centered at the interface. E66 is
also positioned close to K25 as well as R44 in the 40s loop and
likely exerts additional stabilization forces on the interaction
through the formation of salt bridges (Figure 7B). The involve-
ment of E66 and E26 in the interface provides a rationalization
for the reduced oligomerization tendency of mutants in which
these residues are changed to serine or alanine (Czaplewski
et al., 1999).
Comparison of the CCL5 Tetramer to Other Tetramer
Structures
Although there are no structures of oligomers larger than a
dimer for CCL5, a number of higher-order oligomeric structuresll rights reserved
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Structure of the CCL5 Oligomerhave been observed in crystal structures of other chemokines.
Given the conservation of monomer topologies across all
four families of chemokines, and the tendency of most CC
chemokines to form similar ‘‘CC-like dimers’’ and CXC chemo-
kines to form ‘‘CXC-like dimers,’’ there is a surprising number
of different higher-order oligomerization topologies repre-
sented in structural studies of chemokines. Small sequence vari-
ations seem to have large consequences on the stable form
of higher-order oligomers, with structures varying from more
globular forms for tetramers (Lau et al., 2004; Swaminathan
et al., 2003) to more extended forms, where chains as long as
decamers are observed (Murphy et al., 2010; Ren et al., 2010).
Our more extended CCL5 model has a topology most closely
resembling oligomers seen in the recently published crystal
structure of a polymeric form of MIP-1a/b by Ren et al. (2010).
The relative orientation of the dimers in the MIP-1 polymers is
very similar to that of CCL5, and some of the same residues
are involved in forming the tetrameric interface in these
structures. However, the dimer units are translated in our model,
making it somewhat more extended (Figure 7C). This translation
produced a much better fit with the experimental SAXS
profile than a model based directly on the MIP-1a/b structure.
The structural differences between CCL5 and MIP-1 oligomers
appear to arise primarily from sequence variation. Although
they share 42% sequence identity, CCL5 is far more basic
than MIP-1a: the pI for MIP-1a/b is 4.8, whereas the pI for
CCL5 is 9.2. The more basic nature of CCL5 may prevent it
from oligomerizing into a more compact MIP-1a-like structure,
which would bring positively charged residues in close
proximity, creating unfavorable interactions. Furthermore, K25,
which is not present in MIP-1a, appears to be crucial to the
formation of the interface in CCL5, acting as a bridge for the
formation of interdimer electrostatic interactions with both E26
and E66. Without K25, the only favorable electrostatic interac-
tions may be between the GAG-binding motif and E26/E66, as
seen in the MIP-1a oligomer structures. The presence of GAGs
would then compete with the formation of higher oligomers.
The difference in these electrostatic properties and residue-
specific interactions may explain the experimental observation
that GAGs can reduce the oligomerization of WT MIP-1a while
leaving the oligomerization state of its D27Amutant, which forms
an unstable tetramer, untouched (Ren et al., 2010). These same
GAG-binding residues play only a partial role in the formation of
the CCL5 tetramer and are more exposed in the D27A mutant of
MIP1a.
Even greater sequence variations between CCL5 and chemo-
kines such as MCP-1 may explain why CCL5 does not form
a MCP-1 type globular tetramer. Despite having a greater
number of charged residues, MCP-1 has neither the K25/E26
pair nor the 40s BBXB motifs found in CCL5. The lack of these
residues may preclude the formation of CCL5/MIP-1-type linear
oligomers because these motifs play an important role in the
formation of the interface. This leavesMCP-1 to utilize the ‘‘alter-
nate CXC dimer interface’’ at its N terminus to form the globular
tetramer. It also should be noted that formation of CCL5
tetramers similar to MCP-1 would result in the burial of critical
GAG-binding residues in the 40s loop, which would be both
thermodynamically destabilizing and would preclude interac-
tions with GAGs.Structure 19, 1138–Predicted Interactions with GAGs
Given the importance of chemokine oligomerization and GAG
binding in leukocyte migration, it is appropriate to consider
how interactions with GAGs may occur in the context of our
current model, and how they affect the oligomerization process.
Prominent among the residues believed to be involved in GAG
binding are the BBXB motifs constituting residues K44, K45,
N46, R47, and, to a lesser extent, K55 and K56, all of which
are highlighted in red in the octamer model of WT CCL5
(Figure 6B). Notably, all of the residues are solvent accessible,
and their linear arrangement on the surface of the CCL5
oligomer forms sites on which GAG chains could bind. There-
fore, this arrangement offers an explanation for GAG-promoted
chemokine oligomerization (Hoogewerf et al., 1997; Vive`s et al.,
2002). In the absence of GAGs, the electrostatic repulsive force
would keep the size of the CCL5 oligomer small. However,
binding of sulfated GAGs would neutralize repulsive forces
between CCL5 dimers, increasing their aggregation propensity.
This may account for the ability of even low molecular weight
GAGs to cause aggregation (Vive`s et al., 2002; Yu et al.,
2005). Perhaps equally important, the ability of GAG polymers
to bridge the binding sites on multiple chemokine subunits
could have a stabilizing effect on the oligomers through avidity,
somewhat akin to molecular Velcro. Similarly, chemokine oligo-
mers enhance the affinity for GAGs by providing multiple
binding epitopes. Along these lines, heparin is hypothesized
to stabilize an MCP-1 tetramer by bridging all four subunits,
whereas MCP-1 forms primarily dimers in the absence of
GAGs. Furthermore, the affinity of the monomeric form of
MCP-1 for GAG is reduced relative to the WT protein (Lau
et al., 2004).
Simultaneous Interaction with Chemokine
Receptors and GAGs
It is also useful to consider how the formation of chemokine
oligomers and their interactions with GAGs fits into the overall
process of leukocyte extravasation. The consensus mechanism
for this process stipulates that chemokine-induced firm
adhesion of leukocytes to the endothelium occurs after weak
selectin-mediated adhesion (Alon et al., 2003; Lutters et al.,
2004; Miles et al., 2008). If true, oligomerized chemokines
immobilized on the surface of the endothelium via GAGs may
be the first form of chemokine exposed to receptors on leuko-
cytes. Indeed, Weber and coworkers (Baltus et al., 2003)
demonstrated that WT CCL5, but not aggregation-deficient
variants, could induce CCR1-mediated leukocyte arrest, sug-
gesting a role of chemokine oligomers in integrin activation.
This observation further suggests that oligomeric CCL5 bound
to its receptor induces a different set of signals than the mono-
meric form, as may be required at different stages of the
process: leukocyte arrest, migration, and activation (Appay
et al., 1999; Baltus et al., 2003; Salanga and Handel, 2011),
and thus, define the different oligomeric forms as biased
ligands. Some of the residues of CCL5 important for interacting
with CCR5 have been identified by chemical shift perturbation
from titrations with a peptide derived from the CCR5 N
terminus. At low pH (3.8), the peptide has a stronger interaction
with the CCL5 monomer than the dimer, and residues normally
forming the monomer-monomer interface are among the most1148, August 10, 2011 ª2011 Elsevier Ltd All rights reserved 1145
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Structure of the CCL5 Oligomerstrongly perturbed (Duma et al., 2007). This is consistent with
the monomer being involved in the activation of CCR5 at low
concentration. However, at pH 6 the difference in monomer
and dimer behavior decreases, consistent with the fact that
oligomers can also interact at high concentration, and the
most strongly perturbed residues of the N terminus shift to
residues 16, 17, and 23. In Figure 6B these residues are colored
in blue and are shown to be fully accessible for receptor
interaction.
Although never experimentally demonstrated, this line of
thinking also lends itself to the concept that chemokines immo-
bilized on surfaces can simultaneously interact with receptors
and GAGs, and our model suggests mechanisms by which
dual engagement could occur. First, the GAG-binding residues
and the CCR5-interacting residues occupy separate regions on
the surface of CCL5 (Figure 6B), which could permit simulta-
neous interactions. Second, it is possible that GAGs could
interact with some blocks of the polymer while receptors
simultaneously interact with other blocks. However, the most
interesting mechanism suggested by the model is that the linear
arrangement of binding epitopes, offering sequential equivalent
sites for CCR5 interaction, may promote diffusion of leukocytes
along the CCL5 polymer. One-dimensional diffusion offers
well-known advantages over diffusion in two and three dimen-
sions and is exploited in many other cellular contexts (Gorman
and Greene, 2008; Vale et al., 1989). Thus, it is reasonable to
consider that facilitated diffusion on GAG chains could be oper-
ative in cell migration.
EXPERIMENTAL PROCEDURES
Expression of WT and E66S CCL5
Two versions of mature CCL5 were expressed in E. coli using a pET23a vector
with conventional 15NH4Cl containing M9media. They were purified according
to Czaplewski et al. (1999). Briefly, inclusion bodies of CCL5were solubilized in
6 M Gn-HCl and purified on a Superdex 75 column. Purified protein was then
subjected to fast dilution refolding with refolding buffer consisting of 100 mM
Tris (pH 8.0), 100 mM reduced glutathione, and 10 mM oxidized dimeric
glutathione. The refolded protein was then dialyzed against 0.1% TFA and
purified further using strong anion exchange chromatography.
NMR Spectroscopy
NMR samples of CCL5 contained 1–2mMof protein in 50mMacetate buffer at
pH 4.4. RDCs were measured on a 1 mM CCL5 sample aligned in stretched
5% positively charged (Cierpicki and Bushweller, 2004) or neutral polyacryl-
amide gels using the two-stage gel tube as described in Liu and Prestegard
(2010). RDC values were measured using a J-modulated 1H,15N-HSQC exper-
iment (Liu and Prestegard, 2010). Samples for cross-saturationmeasurements
were conducted on a sample consisting of 0.75 mM 15N,2H-labeled protein
mixed with 2.25 mM unlabeled protein in 50% D2O, 50 mM acetate (pH 4.4),
buffer. Cross-saturation experiments were carried out in a manner similar to
that published by Takahashi et al. (2000). Protons were either saturated at 1
or 23 ppm as a control.
SAXS Measurements
SAXS measurements were carried out as described by Wang et al. (2011).
Specifically, samples containing 1–1.25 mM of WT CCL5 at pH 4.5 were irra-
diated for 1 hr with a 1.54 A˚ X-ray source. The scattering pattern was collected
using a Bruker Nanostar U X-ray system and the 2D scattering patterns of both
background and sample were reduced to 1D scattering curves using Bruker’s
SAXS software. The scattering profile was determined as the difference
between samples with andwithout protein. Values formaximumpair distances
were extracted using the program GNOM (Svergun, 1992).1146 Structure 19, 1138–1148, August 10, 2011 ª2011 Elsevier Ltd AModel Screening Using Grid Search, SAXS, and Residue-Pairing
Score
The grid search was conducted in a manner similar to Wang et al. (2008).
Specifically, the crystal structure of the CCL5 dimer (PDB accession code
1U4L) was placed in the alignment tensor principal axes frame such that the
presumed symmetry axis became the x axis of the PDB frame. Another dimer
of CCL5, obtained by rotating the first dimer by 180 around the x axis, was
then translated over a grid on a plane perpendicular to the x axis. Theoretical
SAXS curves of each tetramer/hexamermodel obtained by placing the second
dimer at a different grid point was calculated using CRYSOL (Svergun et al.,
1995) and a hydration shell contrast value of 0.07 e/A˚3. The curves were
then used in OLIGOMER (Konarev et al., 2006) to find the best fit to
a tetramer/hexamer mixture. The interface of each model was evaluated using
a residue-pairing score (Moont et al., 1999), and all models were evaluated
using a combined score, which is obtained by scaling the residue-pairing
score to be in the same numeric range as the SAXS-fitting c2 values for models
with a c2 value of 2.50 or less.
Hydroxyl Radical Footprinting MS
Samples of 15N-labeled CCL5 (E66S mutant or WT) at 20 mM in acetate buffer
(pH 4.5) containing 50 mM H2O2 with 20 mM glutamine to limit radical half-life
were flowed through the beam path of a KrF laser at 248 nm, and pulsed so
that each segment of sample was irradiated with a single 20 ns UV pulse
with a small buffer region between irradiated segments to help account for
sample diffusion and laminar flow effects. The oxidation was immediately
quenched using methionine amide (0.5 mg/ml) and catalase (0.5 mg/ml). Prior
to trypsin digestion, unoxidized and unlabeled mutant or WT CCL5 (20 mM)
was added to the corresponding irradiated samples to serve as an internal
standard for quantitation. After trypsin digestion FT-MS was used to derive
unmodified, unlabeled peptide peaks to unmodified, 15N-labeled peptide
peak ratios for each tryptic peptide, and the fractional oxidation was calcu-
lated from the reduction of ratios compared to an internal standard. Tandem
MSwas used in conjunctionwith LC-MS to identify sites of oxidation, with sites
of oxidation determined by manual annotation of MS/MS spectra.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.str.2011.06.001.
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